YALE ADVANCED FELLOWSHIP IN PULMONARY VASCULAR DISEASE
Yale School of Medicine New Haven, CT
We are accepting applications for the Yale Fellowship in Pulmonary Vascular Disease for the year 2025! We will be accepting applications through July 2024.
Description
The Yale Advanced Fellowship in Pulmonary Vascular Disease is a one-year clinical fellowship. After completing the one-year clinical fellowship, fellows have an option of completing a second year with a focus on research. Potential research opportunities span basic science, translational research, and clinical research within cardiopulmonary physiology and pulmonary vascular disease.
Our clinical training program focuses on the evaluation and management of patients with diseases of the right heart system including pulmonary vascular disease, congenital heart disease, and end stage lung disease. Our program provides trainees with several unique clinical opportunities that are not readily available in most centers and provides a more in-depth and focused training experience than what is provided in general pulmonary and critical care and cardiology training programs.
Physicians who have completed an ACGME accredited fellowship in pulmonary and critical care medicine or cardiovascular medicine are invited to apply. We require the following documents:
- Curriculum vitae (CV)
- Personal statement
- Three letters of recommendation
Further information about the Yale Advanced Fellowship in Pulmonary Vascular Disease can be found on our website: https://medicine.yale.edu/internal-medicine/pulmonary/education/fellowship-pulmonary-vascular-disease/
To Apply
Please feel free to share and distribute to trainees who might be interested. Interested applicants can submit their application and any requests for additional information to:
Sue Porto Fellowship Coordinator Email: [email protected] Phone: 203-785-3207
Inderjit Singh MBChB, BMedSci, FRCP, FCCP Assistant Professor of Medicine Director, Yale Advanced Fellowship in Pulmonary Vascular Disease Email: [email protected]
Posted on March 25, 2024
|